Universiteit Leiden

nl en


LACDR Spring Symposium

Tuesday 24 May 2016

The Leiden Academic Centre for Drug Research, the LACDR,  aims to be one of the leading academic centers in the world in learning, teaching, and in advancing innovative drug research, developing knowledge and expertise crucial for drug discovery, evaluation and (clinical) application. This involves fundamental understanding of drug action as the basis for efficacy and safety of drugs.

About the Symposium:

On the 24th of May 2016, 13.00 – 18.30 hours, the LACDR Spring Symposium will be held in the Gorlaeus Laboratory of the University of Leiden.

During this day we will focus on the research activities of the LACDR PhD students, through a poster presentation and oral presentations. We are very pleased that Prof. dr. Cornelia van Duijn from the Erasmus University Medical Center will give a lecture "Understanding the molecular pathology of complex genetic disorders".

Prof. dr. Thomas Hankemeier will be the chair of the day. Marcel Kenter will give a lecture "A new international advanced master education program for biomedical researches with an entrepreneurial spirit".

It is also the opportunity for interaction between all researchers within the LACDR, students of Bio-Pharmaceutical Sciences, and researchers of the Science faculty.

Please subscribe here: 




Chair: Prof. dr. Thomas Hankemeier

  • 12.00 – 13.00
    Mounting posters by the PhD students
  • 13.00 – 13.05
    Prof. dr. Thomas Hankemeier - Opening
  • 13.05 – 13.35 
    Prof. dr. Cornelia van Duijn – Erasmus University Medical Center
    "Understanding the molecular pathology of complex genetic disorders"
  • 13.35 – 13.50
    Joya Nahon MSc, division of Biopharmaceutics, cluster BioTherapeutics
    "Investigating the role of proteoglycan 4 in atherosclerosis"
  • 13.50 – 14.05
    Amar Oedit MSc, division of Analytical Biosciences, cluster Systems Pharmacology
    "Electroextraction: the next-generation sample extraction technique for metabolomics "
  • 14.05 – 15.05
    Poster presentation with coffee and tea (judging posters odd numbers)
  • 15.05 – 15.20
    Lynn Wester MSc, division of Toxicology, cluster Drug & Target Discovery
    "A kinase inhibitor screen identifies novel therapeutic strategies for antiestrogen drug resistance in breast cancer."
  • 15.20 – 15.35
    Drs. Arnout Mieremet , division of Drug Delivery Technology, cluster BioTherapeutics
    "Chitosan modulated dermal matrix improves epidermal barrier formation in skin models."
  • 15.35 – 15.50
    Jantine Brussee MSc, division of Pharmacology, cluster Systems Pharmacology " Inflammation and organ failure significantly affect CYP3A-mediated midazolam clearance in critically ill children "
  • 15.50 – 16.50
    Poster presentation with coffee and tea (judging posters even numbers)
  • 16.50 – 17.05
    Julia Hillger MSc, division of Medicinal Chemistry, cluster Drug & Target Discovery
    "Getting personal: how genetic variations alter G Protein-Coupled Receptor signaling"
  • 17.05 – 17.15
    Prof. dr. Thomas Hankemeier – concluding remarks
  • 17.15 – 17.30
    Marcel Kenter, PhD – Paul Janssen Futurelab Leiden
    "A new international advanced master education program for biomedical researches with an entrepreneurial spirit"
  • 17.30 – 18.30
    Drinks and presentation of the winners of the PhD competition and poster competition


This website uses cookies.  More information.